📌 Key Takeaways
- Topic: Silica as an Anti-Caking Agent: Mechanism, Dosage and Applications
- Keywords: silicon oxide
- Published: 2026-11-20 02:06:23
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Nanopowder: Particle Size, Specifications and Industrial Uses
- Silica Manufacturer in India: Key Producers, Product Ranges and Export Capabilities
- Costa, J. A. S. & Paranhos, C. M. Mitigation of silica-rich wastes: an option to the synthesis eco-friendly silica-based mesoporous materials. Micropor. Mesopor. Mater. 309, 110570 (2020). Article CAS Google Scholar
- What Is Modified Silica? Surface Modification Methods and Performance Benefits
- Does Silicon Dioxide Conduct Electricity? Why SiO₂ Is an Insulator
- Silica Supplier UAE: How to Source Silica for the UAE and GCC Markets
1250 Mesh Silica: Particle Size, Specifications and Common Applications
What is silica (SiO₂)?
fumed silica supplier
What is the difference between fumed silica and precipitated silica?
Aerosil R972
What drives silica raw material prices?
silica supplier Thailand The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.